Free Trial

Rep. Jefferson Shreve Sells Danaher Corporation (NYSE:DHR) Stock

Danaher logo with Medical background

Representative Jefferson Shreve (R-Indiana) recently sold shares of Danaher Corporation NYSE: DHR. In a filing disclosed on June 22nd, the Representative disclosed that they had sold between $15,001 and $50,000 in Danaher stock on May 12th. The trade occurred in the Representative's "CRT - STANDARD UNIT TRUST" account.

Representative Jefferson Shreve also recently made the following trade(s):

  • Sold $15,001 - $50,000 in shares of Hubbell NYSE: HUBB on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of Trane Technologies NYSE: TT on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of RTX NYSE: RTX on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of NiSource NYSE: NI on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of Johnson & Johnson NYSE: JNJ on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of AppLovin NASDAQ: APP on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of Fiserv NYSE: FI on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of CNO Financial Group NYSE: CNO on 5/12/2025.
  • Sold $50,001 - $100,000 in shares of Cboe Global Markets NASDAQ: CBOE on 5/12/2025.
  • Sold $15,001 - $50,000 in shares of Lam Research NASDAQ: LRCX on 5/12/2025.

Danaher Trading Up 1.4%

Shares of NYSE:DHR traded up $2.79 during trading on Friday, hitting $205.60. The company had a trading volume of 5,355,676 shares, compared to its average volume of 3,965,185. The stock has a market cap of $147.22 billion, a price-to-earnings ratio of 43.74, a price-to-earnings-growth ratio of 2.86 and a beta of 0.77. Danaher Corporation has a one year low of $171.00 and a one year high of $281.70. The company has a fifty day simple moving average of $196.38 and a two-hundred day simple moving average of $203.68. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.05.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The company's revenue for the quarter was up 3.4% on a year-over-year basis. During the same period last year, the company earned $1.72 EPS. As a group, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, July 25th. Stockholders of record on Friday, June 27th were paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.62%. Danaher's payout ratio is 27.23%.

Insider Activity

In related news, EVP Christopher Paul Riley sold 15,805 shares of the company's stock in a transaction dated Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the transaction, the executive vice president directly owned 15,179 shares of the company's stock, valued at $3,005,442. This represents a 51.01% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction dated Monday, May 12th. The shares were sold at an average price of $196.74, for a total value of $245,925,000.00. Following the completion of the transaction, the chairman directly owned 3,105,808 shares in the company, valued at $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 11.10% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of several analyst reports. Leerink Partners raised their price objective on Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a research note on Wednesday, April 23rd. Wall Street Zen raised Danaher from a "hold" rating to a "buy" rating in a research note on Friday, June 27th. Deutsche Bank Aktiengesellschaft decreased their price target on Danaher from $240.00 to $235.00 in a research note on Thursday, June 5th. Barclays reissued an "overweight" rating and set a $225.00 price target (up from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Finally, Wolfe Research decreased their target price on Danaher from $275.00 to $220.00 and set an "outperform" rating for the company in a research report on Monday, April 7th. Three research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $247.61.

View Our Latest Stock Analysis on DHR

Institutional Investors Weigh In On Danaher

A number of hedge funds have recently made changes to their positions in the stock. FAS Wealth Partners Inc. increased its position in Danaher by 20.6% during the 4th quarter. FAS Wealth Partners Inc. now owns 9,597 shares of the conglomerate's stock valued at $2,203,000 after buying an additional 1,639 shares in the last quarter. Asahi Life Asset Management CO. LTD. acquired a new position in Danaher during the 1st quarter valued at about $539,000. Horizon Financial Services LLC increased its position in Danaher by 20,400.0% during the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock valued at $1,681,000 after buying an additional 8,160 shares in the last quarter. Charles Schwab Investment Management Inc. increased its position in Danaher by 3.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,066,755 shares of the conglomerate's stock valued at $933,524,000 after buying an additional 135,047 shares in the last quarter. Finally, Vision Capital Management Inc. acquired a new position in Danaher during the 1st quarter valued at about $461,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

About Representative Shreve

Jefferson Shreve (Republican Party) is a member of the U.S. House, representing Indiana's 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Shreve (Republican Party) is running for re-election to the U.S. House to represent Indiana's 6th Congressional District. He declared candidacy for the 2026 election. Email editor@ballotpedia.org to notify us of updates to this biography. Jefferson Shreve earned a bachelor's degree from Indiana University in 1989, a graduate degree from the University of London in 1998, and a graduate degree from Purdue University in 2003. Shreve's career experience includes working as a real estate executive. Shreve was elected 7th District Vice Chairman of the Indiana Republican State Committee on January 17, 2018, and was re-elected on March 6, 2021. In 2020, he was selected as a district-level delegate to the 2020 Republican National Convention.

Danaher Company Profile

(Get Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

See Also

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines